Vietnamese, Israeli firms sign cooperation agreement on oral COVID-19 vaccine
Vietnam’s Tan Thanh Holdings and 10 Pharma JSC will be distributors of COVID-19 vaccine Oravax throughout Southeast Asian nations, comprising Vietnam, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore and Thailand.
Oravax Medical of Israel's Oramed Pharmaceuticals and the Vietnamese firms signed the cooperation agreement of oral COVID-19 vaccine Oravax at a ceremony held online on December 29.
Nadav Kidron, Chief Executive of Oramed and Oravax Chairman, said the deal, worth hundreds of millions of US dollars for Oravax, includes pre-order of oral vaccine.
He viewed Tan Thanh Holdings as an ideal partner for his business to bring the oral vaccine to Vietnam and other ASEAN member countries that have a combined population of over 660 million.
Addressing the signing ceremony, Vietnamese Ambassador to Israel Do Minh Hung stressed the significance of the cooperation, saying this is the first time Vietnam and Israel have cooperated in high-tech health care, both in terms of trade and technology transfer.
The cooperation contents match guidelines of the Vietnamese Government and meet domestic demand for vaccine access, he said.
